Loading clinical trials...
Loading clinical trials...
Breast cancer is the most common malignant disease and the most frequent causes of cancer mortality in females worldwide. The situation is same as the world in China. Trastuzumab has been proved valua...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Shanghai CP Guojian Pharmaceutical Co., Ltd.
NCT07453342 · Immune-Related Adverse Events
NCT06117176 · Airway Complication of Anesthesia, Adverse Events
NCT07167251 · Immune Related Adverse Events, Immune-Mediated Hepatitis, and more
NCT07090525 · Overall Response Rate
NCT06789601 · Malignancy, Immune Related Adverse Events
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions